<p><strong>Knee Osteoarthritis Overview</strong></p>
<p>Knee osteoarthritis (OA), also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage. It is most common in the elderly and can be divided into two types, primary and secondary. Primary osteoarthritis is articular degeneration without any apparent underlying reason. Secondary osteoarthritis is the consequence of either an abnormal concentration of force across the joint, as with post-traumatic causes, or abnormal articular cartilage, such as rheumatoid arthritis (RA).</p>
<h2><strong>Knee Osteoarthritis Epidemiology Segmentation in the 7MM</strong></h2>
<ul>
<li>Prevalent population of Knee Osteoarthritis</li>
<li>Gender-specific distribution of Knee Osteoarthritis</li>
<li>Severity-specific prevalence of Knee Osteoarthritis</li>
<li>Age-specific distribution of Knee Osteoarthritis</li>
</ul>
<h3><strong>Knee Osteoarthritis Epidemiological Insights Observed in the 7MM (2021)</strong></h3>
<p>The total prevalent cases of Knee Osteoarthritis in the 7MM was approximately <strong>48 Million in the year 2021</strong>.</p>
<h2><strong><a href="https://www.delveinsight.com/report-store/knee-osteoarthritis-market"><span style="text-decoration: underline;">Knee Osteoarthritis Market Insight</span></a>&nbsp;</strong></h2>
<p>The market size of Knee Osteoarthritis in the 7MM is approximately <strong>~USD 14 Billion in the year 2021.</strong></p>
<h3><strong>Knee Osteoarthritis Market Strengths</strong></h3>
<ul>
<li>Many key players are developing cell therapies for knee OA, which are in various stages of development. These therapies, if approved, may provide better treatment options as it can slow disease progression and may possibly cure the disease.</li>
</ul>
<h3><strong>Knee Osteoarthritis&nbsp; Market Opportunities</strong></h3>
<ul>
<li>For the treatment of Knee OA, usage of opioids can be seen. The majority of patients/physicians are eagerly waiting for nonopioid options, and key players can target this lucrative segment of the market&nbsp;</li>
</ul>
<h3><a href="https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight"><span style="text-decoration: underline;"><strong>Knee Osteoarthritis Emerging drugs</strong></span></a></h3>
<p>The emerging drugs in the Knee Osteoarthritis market are</p>
<ul>
<li>LNA043</li>
<li>AMPION&nbsp;</li>
<li>TLC599</li>
<li>CNTX-4975</li>
<li>LORECIVIVINT (SM04690)</li>
<li>AMNIOFIX</li>
<li>RENU (AMNIOTIC SUSPENSION ALLOGRAFT)</li>
<li>INVOSSA (TG-C)</li>
<li>ZILOSUL (PENTOSAN POLYSULFATE SODIUM)</li>
<li>WEGOVY (SEMAGLUTIDE)</li>
<li>JOINTSTEM</li>
<li>TTAX03</li>
<li>X0002</li>
<li>RTX (MCP-101; RESINIFERATOXIN)</li>
<li>APPA</li>
<li>SPRIFERMIN</li>
<li>CARTISTEM</li>
<li>MIV-711</li>
</ul>
<h3><strong>Knee Osteoarthritis key players</strong></h3>
<p>The key players working in the&nbsp; Knee Osteoarthritis market are</p>
<ul>
<li>Novartis</li>
<li>Ampio Pharmaceuticals</li>
<li>Taiwan Liposome Company</li>
<li>Centrexion Therapeutics</li>
<li>Biosplice Therapeutics</li>
<li>Mimedx</li>
<li>Organogenesis</li>
<li>Kolon Tissuegene</li>
<li>Paradigm Biopharma</li>
<li>Novo Nordisk</li>
<li>Nature Cell</li>
<li>Tissuetech</li>
<li>Techfields Pharma</li>
<li>Sorrento Therapeutics</li>
<li>Grunenthal</li>
<li>Akl Research And Development</li>
<li>Merck Kgaa</li>
<li>Trialspark</li>
<li>Medipost</li>
<li>Medivir</li>
</ul>

Knee Osteoarthritis Market

Knee Osteoarthritis Market Infographics

Knee Osteoarthritis Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape